Provider review · Updated September 29, 2026
UCLA weight-care records: nutrition-program charges do not identify a prescription
UCLA’s Medical Weight Management Program publishes assessment, maintenance and fee information. These records concern clinical nutrition, not a verified GLP-1 offer.
Editorial document research. No clinician review or firsthand treatment experience claimed.
UCLA Health gives unusually concrete financial information for its Medical Weight Management Program. That can make the service easier to understand, provided the charges remain attached to the clinical nutrition program that publishes them. A price beside a health-system name is not automatically a price for semaglutide or another prescription medicine.
This September 29, 2026 review considers the program overview, maintenance description and fee page. It documents the distinctions between assessment, ongoing participation and additional charges without assuming GLP-1 prescribing. No personal consultation, insurance decision or enrollment was tested, and the record does not verify a UCLA microdosing offer.
The service starts with a nutrition-focused assessment
The program overview describes an initial comprehensive assessment involving medical information, current medications, measurements and testing. Physician and dietitian involvement gives it a clinical role. Its published pathways are nutrition and weight-management programs, rather than a verified prescription-drug catalogue.
That identity needs to stay visible when the service appears beside medicine-focused reviews. A medication history collected during assessment is not evidence that a new GLP-1 medicine will be supplied. The same is true of medical monitoring: it describes care responsibility, not the contents of a pharmacy order. The public material supports this particular program without settling treatment selection for an individual reader.
Insurance language belongs to this specific program
The program fee page says the program is not covered by insurance and does not bill insurance. This is a specific financial statement about the Medical Weight Management Program. It should not be expanded into a claim about all UCLA clinical services or every weight-related appointment in the health system.
The Stanford review concerns a different service whose pages describe insurance navigation. Those records can be compared for their meanings, but their payment rules cannot be exchanged. UCLA's published no-billing statement is more definite than a general network list, while still leaving a reader's unrelated care and outside expenses beyond this program's record.
Separate the first charge from the recurring fee
As reviewed, the fee page lists an initial visit at $150, plus any nutritional products. It then lists monthly program fees collected one week after that visit and due on that date in subsequent months. The stated monthly amounts are $295 for the very-low-calorie or modified very-low-calorie pathways, $225 for the low-calorie pathway and $90 for maintenance, each plus nutritional products.
These are program charges, not recommended dietary or medicine instructions. The monthly-price guide helps separate a collection date from what the charge covers. None of these figures establishes a semaglutide price, prescription amount, shipment or selected treatment.
Extra appointments and products remain separate
The same fee page says physician or dietitian visits outside the standard schedule can carry additional charges. It places the frequency discussion at the initial visit and relates it to the program followed. Nutritional products are also separately priced rather than silently absorbed into the headline service amount.
The offer-record comparison is useful here because “monthly program” can sound more inclusive than the actual terms. The reviewed page does not establish a complete personal total or a cancellation and refund agreement. Its specificity about some charges should not be used to invent the terms that are absent, or to relabel nutritional products as prescription medicines.
Maintenance describes continuing support
UCLA's maintenance page describes monthly individual meetings with a dietitian and access to group support classes. Those features explain the ongoing service. They do not establish that every physician visit is included or that maintenance means a prescription refill program.
The Northwestern review also keeps a nutrition service separate from medicine and from another program under the same institutional name. Here, the maintenance description and fee page should be read together without merging their different jobs. One describes support; the other explains published charges and extras. Neither identifies a personally selected drug or verifies a particular patient's outcomes.
A clinical program does not resolve product identity
No confirmed GLP-1 prescribing offer appears in these cited UCLA nutrition-program records. That is a limit of this review's evidence, not a statement that such care cannot exist elsewhere in UCLA Health. A broad institutional association cannot supply the missing product detail.
FDA's drug-product terminology concerns the finished medicine. Our guide to formulation words explains why an ingredient name or container description is not a personal instruction. For this program, the earlier question is even simpler: these documents do not identify such a prescription at all. A clinical assessment and a recurring nutrition fee should therefore remain separate from any medicine a patient might discuss elsewhere.
Do not turn older logistics into present guarantees
The program overview includes older pandemic-related wording about group arrangements and says schedules may change. That material should not be converted into a current promise that every element is remote, available at a fixed time or included without qualification.
The service record remains useful when those limits stay attached. It documents clinical nutrition assessment, maintenance support and specific program charges. It does not settle a complete personal bill, cancellation rights, current appointment logistics or an exact drug offer. Readers can distinguish what is published from what would need an individual document, without mistaking a medical setting for proof of medicine inclusion or a particular safety outcome.
Sources for this article
- Medical Weight Management Program Overview ↗Official Medical Weight Management Program overview centered on clinical nutrition. Medication review does not verify GLP-1 prescribing. Visit schedules may change, and older COVID-related class wording does not confirm current access. · Checked 2026-09-29
- Weight Management Program Costs ↗Official nutrition-program fee page stating no insurance coverage or insurance billing. Initial and monthly fees, nutritional products and extra visits are separate; collection dates are not medicine instructions, drug prices or verified refund terms. · Checked 2026-09-29
- Weight Maintenance Program ↗Official nutrition-program maintenance description of monthly dietitian meetings and group support. This does not identify a prescription refill program or show that every extra physician service is included. · Checked 2026-09-29
- Drugs@FDA Glossary of Terms ↗FDA definitions of active ingredient, dosage form and finished drug product. Terminology alone does not approve an unspecified preparation, confirm availability or supply personal treatment instructions. · Checked 2026-09-29